January 9, 2018
New Tamper Evident Labeller from LSS
LSS Labelling Systems Scandinavia, a Denmark-based supplier of labelling solutions will launch a new Tamper Evident labelling machine for the pharmaceutical industry at…
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
January 9, 2018
BD to repurchase its 3.000% notes due 2026
BD has started an offer to repurchase all of its outstanding 3.000% Notes until May 15, 2026 that were issued…
January 8, 2018
Amryt to distribute Lojuxta with RCC Pharma in Switzerland
Amryt, a biopharmaceutical company focused on rare and orphan diseases, has signed an agreement for distributing its Lojuxta through RCC…
January 8, 2018
Sanofi and Regeneron to boost investment for two development programs
Sanofi and Regeneron Pharmaceuticals said they will accelerate and expand investment for the clinical development of the PD-1 (programmed cell…
January 8, 2018
Horizon Pharma’s MEDI4945 has potential for subcutaneous dosing and reduced immunogenicity?
Horizon Pharma has licensed the global rights to MEDI4945, a pre-clinical, genetically engineered uricase derivative combined with site-specific PEGylation, from…
January 8, 2018
Good news for Matinas BioPharma’s treatment for Chronic Refractory Mucocutaneous Candidiasis
Matinas BioPharma Holdings said Monday that the National Institutes of Health (NIH) has revealed positive data from a third patient…
January 8, 2018
Faller with three prototypes in line with the theme of smart packaging at Pharmapack 2018
Faller, a German-based player in packaging in the pharma industry is presenting three prototypes in line with the theme of…
January 8, 2018
Calgene Corp buys Impact Biomedicines for $2,3 billion
Celgene Corporation and Impact Biomedicines have agreed for Celgene to acquire Impact Biomedicines, which is developing fedratinib for myelofibrosis and…
January 8, 2018
Novo Nordisk in Ablynx €2.6 Billion buy
Novo Nordisk on Monday confirmed proposing on December 22, 2017 to acquire Ablynx for €28.00 per share in cash and…
January 8, 2018
Targovax welcomes new business leader
Targovax ASA, a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, announced on Monday that Michael…